The global industry for Active Pharmaceutical Ingredient (API) suppliers is a complex landscape, covering numerous locations. PRC currently dominates the manufacturing of APIs, followed by India, which is a major player in both off-patent API distribution. European businesses, particularly in countries like Germany, Switzerland, and Italy, maintain